Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy

Van Poppel, 2021, A European model for an organised risk-stratified early detection programme for prostate cancer, Eur Urol Oncol, 4, 731, 10.1016/j.euo.2021.06.006 Mottet, 2021, EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent, Eur Urol, 79, 243, 10.1016/j.eururo.2020.09.042 Van Poppel, 2021, Early detection of prostate cancer in 2020 and beyond: facts and recommendations for the European Union and the European Commission, Eur Urol, 79, 327, 10.1016/j.eururo.2020.12.010 Roobol, 2010, A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer, Eur Urol, 57, 79, 10.1016/j.eururo.2009.08.025 van Leenders, 2020, Improved prostate cancer biopsy grading by incorporation of invasive cribriform and intraductal carcinoma in the 2014 grade groups, Eur Urol, 77, 191, 10.1016/j.eururo.2019.07.051 Kweldam, 2016, Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma, Eur J Cancer, 66, 26, 10.1016/j.ejca.2016.07.012 van Leenders, 2020, The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma, Am J Surg Pathol, 44, e87, 10.1097/PAS.0000000000001497 Roobol, 2017, Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer risk calculator for initial prostate biopsy by incorporating the 2014 International Society of Urological Pathology Gleason grading and cribriform growth, Eur Urol, 72, 45, 10.1016/j.eururo.2017.01.033 Postma, 2007, Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) – Section Rotterdam: a comparison of two rounds of screening, Eur Urol, 52, 89, 10.1016/j.eururo.2007.01.030 Alberts, 2019, Prediction of high-grade prostate cancer following multiparametric magnetic resonance imaging: improving the Rotterdam European Randomized Study of Screening for Prostate Cancer risk calculators, Eur Urol, 75, 310, 10.1016/j.eururo.2018.07.031 Van Poppel H, Roobol MJ, Chapple CR, et al. Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology position and recommendations for 2021. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.07.024.